Spigel DR, Dowlati A, Chen Y, Navarro A, et al. RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer. J Clin Oncol 2024 Apr 22:JCO2302110. doi: 10.1200/JCO.23.02110.
PMID: 38648575